GlassScriptPhysician profile
Daria Korneva
NPI 1609532183
$5,074.61
in general payments reported to CMS, 2019-2025
34 companies · $1,389 in 2025
The $1,389 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $836 · 2023: $1,564 · 2024: $1,286 · 2025: $1,389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,160 · Gift: $59.40 · Long Term Medical Supply Or Device Loan: $19.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,159.62 |
| Gift | $59.40 |
| Long Term Medical Supply Or Device Loan | $19.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $940.74 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $702.62 | 2022-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $659.48 | 2023-2025 | Farxiga, Lokelma |
| Novo Nordisk INC | $415.83 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $386.05 | 2022-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $304.41 | 2022-2025 | Evenity, Prolia, Tepezza |
| Corcept Therapeutics | $199.55 | 2025 | Korlym |
| Mannkind Corporation | $185.00 | 2022-2025 | Afrezza |
| Xeris Pharmaceuticals, INC. | $166.96 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Medtronic, INC. | $143.30 | 2022-2024 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Sanofi-Aventis U.S. LLC | $139.27 | 2022-2025 | |
| Cequr Corporation | $123.16 | 2022-2025 | Cequr Simplicity |
| Insulet Corporation | $104.84 | 2024-2025 | Omnipod |
| Tandem Diabetes Care, INC. | $73.03 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Bayer Healthcare Pharmaceuticals INC. | $70.27 | 2024-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $52.84 | 2024-2025 | Xyosted |
| Tolmar, INC. | $49.80 | 2025 | Jatenzo |
| Amphastar Pharmaceuticals, INC. | $49.60 | 2023-2025 | Baqsimi |
| Verity Pharmaceuticals INC. | $31.37 | 2024-2025 | Tlando |
| Ibsa Pharma INC. | $30.63 | 2023-2025 | Tirosint, Flector, Licart |
| Becton, Dickinson and Company | $29.92 | 2022 | |
| Glaxosmithkline, LLC. | $27.83 | 2022-2023 | Trelegy Ellipta |
| Abbott Laboratories | $19.98 | 2025 | Freestyle Insulinx |
| Alkermes, INC. | $19.47 | 2025 | Vivitrol |
| Dynavax Technologies Corporation | $17.29 | 2024 | Heplisav-B |
| Esperion Therapeutics, INC. | $16.80 | 2023 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.17 | 2024 | Xifaxan, Trulance |
| Lundbeck LLC | $15.51 | 2023 | Rexulti |
| Sanofi Pasteur INC. | $15.00 | 2023 | |
| Novartis Pharmaceuticals Corporation | $14.85 | 2024 | |
| Embecta Corp. | $14.67 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Amryt Pharma Holdings LTD | $14.38 | 2022 | |
| Collegium Pharmaceutical, INC. | $12.46 | 2022 | |
| Phathom Pharmaceuticals, INC. | $11.53 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daria Korneva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.